ICICI Prudential Nifty Pharma Index Fund - Direct Plan - Growth
ICICI Prudential Mutual Fund · Index & ETF · mandate: passive replication of the stated index · tracks: Nifty Pharma
AUM (all plans)
122 cr
TER direct / regular
0.48% / 1.15%
Tracks (from name)
Nifty Pharma
CAGR (full)
22.2%
Sharpe (full)
0.97
Sharpe (bull ≤Sep-24)
2.57
Sharpe (sideways Oct-24→)
0.12
Max drawdown
-15.2%
Months of data
44
Percentile ranks this fund within its peer pool; the leaderboard Score is
the weighted average of its fiscal-year percentiles (equity: active-return-rank blended
with IR-rank).
Equity curve
Drawdown
Fiscal-year record
FY
Return
vs category
Sharpe
months
FY22
—
—
—
0
FY23*
-4.4%
-3.2%
-1.94
3
FY24
56.9%
31.7%
2.61
12
FY25
11.3%
1.7%
0.33
12
FY26
5.4%
9.6%
0.00
12
FY27*
18.6%
7.2%
4.37
5
Active/Fund returns are TOTALS over the months covered — never annualized
(FY27* is year-to-date; a * row covers only part of the year).
%ile is the fund's percentile within its peer pool for that year.
Monthly returns (%)
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Year
2023
-1.9
-4.7
+2.2
+4.9
+0.1
+8.4
+9.2
+0.5
+2.1
-4.9
+10.5
+3.6
+32.9
2024
+6.5
+6.1
-0.1
-0.2
-1.0
+4.8
+10.5
+6.8
+0.2
-2.4
-2.2
+5.2
+38.8
2025
-8.4
-7.4
+6.6
+3.0
-1.5
+2.9
+3.6
-4.3
-1.6
+3.3
+3.7
-1.2
-2.6
2026
-4.5
+5.9
-3.2
+4.6
+4.6
+4.1
+4.9
-0.7
+16.2
Quarterly average AUM & estimated net flows
Quarterly net flow estimate: AUM_q − AUM_(q−1)·(1+quarter return). AUM shown is the quarter AVERAGE (AMFI central disclosure). Positive = net inflows, ₹cr.
Source: AMFI's official all-scheme NAV history (portal report; official NAV history, net of TER by
construction). Monthly returns are month-end NAV chains; stale prints (>7 days before
month-end) drop out rather than carry. Benchmark series are the median of plain-vanilla
direct-plan index funds tracking each index (TRI minus ~10-25bp/yr tracking drag — verified
against true-TRI chains). Direct plans, growth option only. Sharpe uses rf 6%, arithmetic
monthly convention. Independence: all figures are computed from mandatory public disclosures with a
fixed methodology applied identically to every fund — no fund can pay for inclusion,
exclusion, placement, or altered presentation, and any material commercial relationship
will be disclosed on the affected pages.
Nothing here is investment advice; past performance does not
predict future returns. Generated 2026-08-25 05:37Z · data through Aug 2026 · leaderboard
· PMS leaderboard